Pamela K. Green

2.9k total citations · 3 hit papers
29 papers, 2.0k citations indexed

About

Pamela K. Green is a scholar working on Epidemiology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Pamela K. Green has authored 29 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 21 papers in Hepatology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Pamela K. Green's work include Liver Disease Diagnosis and Treatment (19 papers), Hepatitis C virus research (16 papers) and Liver Disease and Transplantation (10 papers). Pamela K. Green is often cited by papers focused on Liver Disease Diagnosis and Treatment (19 papers), Hepatitis C virus research (16 papers) and Liver Disease and Transplantation (10 papers). Pamela K. Green collaborates with scholars based in United States, South Africa and Vietnam. Pamela K. Green's co-authors include George N. Ioannou, Kristin Berry, Lauren A. Beste, Steven L. Leipertz, Jason A. Dominitz, David B. Ross, Feng Su, Michael F. Chang, Judith I. Tsui and Akbar K. Waljee and has published in prestigious journals such as Gastroenterology, Hepatology and Diabetes Care.

In The Last Decade

Pamela K. Green

29 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma

2017 386 citations George N. Ioannou, Pamela K. Green et al. Journal of Hepatology profile →
Trends in Burden of Cirrhosis and Hepatocellular Carcinoma by Underlying Liver Disease in US Veterans, 2001–2013

2015 374 citations Lauren A. Beste, Pamela K. Green et al. Gastroenterology profile →
Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores

2019 233 citations George N. Ioannou, Lauren A. Beste et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pamela K. Green United States	20	1.6k	1.6k	130	107	106	29	2.0k
Julia Uhanova Canada	21	663 0.4×	773 0.5×	85 0.7×	124 1.2×	76 0.7×	70	1.2k
Chris Estes United States	14	2.4k 1.5×	2.3k 1.4×	54 0.4×	52 0.5×	352 3.3×	25	2.7k
Rena K. Fox United States	15	697 0.4×	699 0.4×	51 0.4×	133 1.2×	43 0.4×	26	1.0k
Anne Minello France	24	1.2k 0.7×	1.2k 0.7×	227 1.7×	363 3.4×	108 1.0×	51	1.6k
Tram T. Tran United States	24	1.5k 0.9×	1.7k 1.1×	91 0.7×	371 3.5×	241 2.3×	84	2.5k
Ponni Perumalswami United States	20	861 0.5×	903 0.6×	55 0.4×	74 0.7×	209 2.0×	86	1.2k
Anthony Yartel United States	9	1.4k 0.9×	1.4k 0.8×	49 0.4×	30 0.3×	128 1.2×	19	1.6k
Alnoor Ramji Canada	21	1.2k 0.7×	1.2k 0.7×	39 0.3×	192 1.8×	168 1.6×	82	1.4k
Katherine Stuart Australia	23	834 0.5×	859 0.5×	90 0.7×	253 2.4×	58 0.5×	73	1.6k
Walid S. Ayoub United States	21	992 0.6×	1.1k 0.7×	106 0.8×	388 3.6×	51 0.5×	65	2.0k

Countries citing papers authored by Pamela K. Green

Since Specialization

Citations

This map shows the geographic impact of Pamela K. Green's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela K. Green with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela K. Green more than expected).

Fields of papers citing papers by Pamela K. Green

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela K. Green. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela K. Green. The network helps show where Pamela K. Green may publish in the future.

Co-authorship network of co-authors of Pamela K. Green

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela K. Green. A scholar is included among the top collaborators of Pamela K. Green based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela K. Green. Pamela K. Green is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vutien, Philip, Nicole J. Kim, Andrew M. Moon, et al.. (2023). Hepatocellular carcinoma risk decreases as time accrues following hepatitis C virus eradication. Alimentary Pharmacology & Therapeutics. 59(3). 361–371. 13 indexed citations

Vutien, Philip, Kristin Berry, Ziding Feng, et al.. (2022). Combining FIB-4 and Liver Stiffness Into the FIB-5, a Single Model that Accurately Predicts Complications of Portal Hypertension. The American Journal of Gastroenterology. 117(12). 1999–2008. 10 indexed citations

Ioannou, George N., Emily R. Locke, Pamela K. Green, & Kristin Berry. (2022). Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A target trial emulation study in the U.S. Veterans Affairs healthcare system. EClinicalMedicine. 45. 101326–101326. 27 indexed citations

Johnson, Kay M., Kira L. Newman, Kristin Berry, et al.. (2022). Risk factors for adverse outcomes in emergency versus nonemergency open umbilical hernia repair and opportunities for elective repair in a national cohort of patients with cirrhosis. Surgery. 172(1). 184–192. 10 indexed citations

Ioannou, George N., Lauren A. Beste, Pamela K. Green, et al.. (2019). Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores. Gastroenterology. 157(5). 1264–1278.e4. 233 indexed citations breakdown →

Tapper, Elliot B., Neehar D. Parikh, Pamela K. Green, et al.. (2019). Reduced Incidence of Hepatic Encephalopathy and Higher Odds of Resolution Associated With Eradication of HCV Infection. Clinical Gastroenterology and Hepatology. 18(5). 1197–1206.e7. 19 indexed citations

Wong, Susan, Margaret K. Yu, Pamela K. Green, et al.. (2018). End-of-Life Care for Patients With Advanced Kidney Disease in the US Veterans Affairs Health Care System, 2000-2011. American Journal of Kidney Diseases. 72(1). 42–49. 40 indexed citations

Ioannou, George N., Pamela K. Green, Lauren A. Beste, et al.. (2018). Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C. Journal of Hepatology. 69(5). 1088–1098. 99 indexed citations

Ioannou, George N., Pamela K. Green, & Kristin Berry. (2017). HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma. Journal of Hepatology. 68(1). 25–32. 386 indexed citations breakdown →

10.

Hum, Justine, Janice H. Jou, Pamela K. Green, et al.. (2017). Improvement in Glycemic Control of Type 2 Diabetes After Successful Treatment of Hepatitis C Virus. Diabetes Care. 40(9). 1173–1180. 109 indexed citations

11.

Beste, Lauren A., et al.. (2017). Effectiveness of hepatitis C antiviral treatment in a USA cohort of veteran patients with hepatocellular carcinoma. Journal of Hepatology. 67(1). 32–39. 89 indexed citations

12.

Su, Feng, Pamela K. Green, Kristin Berry, & George N. Ioannou. (2016). The association between race/ethnicity and the effectiveness of direct antiviral agents for hepatitis C virus infection. Hepatology. 65(2). 426–438. 57 indexed citations

13.

Tsui, Judith I., Emily C. Williams, Pamela K. Green, et al.. (2016). Alcohol use and hepatitis C virus treatment outcomes among patients receiving direct antiviral agents. Drug and Alcohol Dependence. 169. 101–109. 55 indexed citations

14.

Ioannou, George N., Lauren A. Beste, Michael F. Chang, et al.. (2016). Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System. Gastroenterology. 151(3). 457–471.e5. 171 indexed citations

15.

Beste, Lauren A., Pamela K. Green, & George N. Ioannou. (2014). Boceprevir and telaprevir-based regimens for the treatment of hepatitis C virus in HIV/HCV coinfected patients. European Journal of Gastroenterology & Hepatology. 27(2). 123–129. 4 indexed citations

16.

Ioannou, George N., Lauren A. Beste, & Pamela K. Green. (2013). Similar Effectiveness of Boceprevir and Telaprevir Treatment Regimens for Hepatitis C Virus Infection on the Basis of a Nationwide Study of Veterans. Clinical Gastroenterology and Hepatology. 12(8). 1371–1380. 42 indexed citations

17.

Saver, Barry G., Ching-Yun Wang, Sharon A. Dobie, Pamela K. Green, & Laura–Mae Baldwin. (2013). The central role of comorbidity in predicting ambulatory care sensitive hospitalizations*. European Journal of Public Health. 24(1). 66–72. 36 indexed citations

18.

Saver, Barry G., et al.. (2009). No Pain, But No Gain? The Disappearance of Angina Hospitalizations, 1992–1999. Medical Care. 47(10). 1106–1110. 9 indexed citations

19.

Baldwin, Laura, Barry G. Saver, Sharon A. Dobie, et al.. (2009). The Contribution of Longitudinal Comorbidity Measurements to Survival Analysis. Medical Care. 47(7). 813–821. 25 indexed citations

20.

Green, Pamela K., Noel S. Weiss, Barbara McKnight, Lynda F. Voigt, & Shirley A.A. Beresford. (1996). Risk of endometrial cancer following cessation of menopausal hormone use (Washington, United States). Cancer Causes & Control. 7(6). 575–580. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact